MedPath

Comparison of azithromycin and erythromycin effect in reducing complications of preterm premature rupture of membranes: a clinical trial study

Phase 1
Recruiting
Conditions
preterm premature rupture of membranes (PPROM).
Registration Number
IRCT20230129057268N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

Women with a gestational age of more than 24 weeks will be included in this study.

Exclusion Criteria

Women with a gestational age of less than 24 weeks, women with a cerclage, history of smoking, trauma or injury that led to PPROM , a congenital or fatal fetal anomaly, and those that consumed other antibiotics before referral, will be excluded from the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath